The Wnt antagonist sFRP1 as a favorable prognosticator in human biliary tract carcinoma

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Kang, Pengcheng ^a   Wan, Ming ^a   Huang, Peng ^a   Li, Chunlong ^a   Wang, Zhidong ^a   Zhong, Xiangyu ^a   Hu, Zhanliang ^a   Tai, Sheng ^a   Cui, Yunfu ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; SECRETED FRIZZLED RELATED PROTEIN 1; WNT PROTEIN; MEMBRANE PROTEIN; SFRP1 PROTEIN, HUMAN; SIGNAL PEPTIDE; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COLLOID CARCINOMA; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WNT SIGNALING PATHWAY; BILIARY TRACT TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

BETA CATENIN; BILIARY TRACT NEOPLASMS; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84896912355     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090308     Document Type: Article

References (43)

1. Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM (2000) Biliary tract cancers. N Engl J Med 342:663-664.
2. Shaib Y, El-Serag HB (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115-125. (Pubitemid 38738341)
3. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303-1314. (Pubitemid 41416587)
4. Blechacz B, Gores GJ (2008) Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48:308-321. (Pubitemid 351975555)
5. Malhi H, Gores GJ (2006) Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 45:856-867. (Pubitemid 44646688)
6. Jarnaqin WR, Shoup M (2004) Surgical management of cholangiocarcinoma. Semin. Liver Dis 24:189-199.
7. Blechacz B, Gores GJ (2008) Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48:308-321. (Pubitemid 351975555)
8. Cadiqan KM, Nusse R (1997) Wnt signaling: a common theme in animal development. Genes Dev. 11:3286-3305.
9. Zong Y, Stanger BZ (2011) Molecular mechanisms of bile duct development. Int J Biochem Cell Biol 43:257-264.
10. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, et al. (1996) Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382: 638-642. (Pubitemid 26268958)
11. Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, et al. (1999) Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 96:1603-1608. (Pubitemid 29098498)
12. Tetsu O, McCormick F (1999) β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426. (Pubitemid 29180374)
13. Giles RH, van Es JH, Clevers H (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653:1-24. (Pubitemid 36627817)
14. Lustig B, Behrens J (2003) The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 129:199-221. (Pubitemid 36713796)
15. Wong CM, Fan ST, Ng IO (2001) β-catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer 92:136-145. (Pubitemid 32623050)
16. Uren A, Reichsman F, Anest V, Taylor WG, Muraiso K, et al. (2000) Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J Biol Chem 275:4374-4382. (Pubitemid 30094680)
17. Bafico A, Gazit A, Pramila T, Finch PW, Yaniv A, et al. (1999) Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling. J Biol Chem 274:16180-16187.
18. Takada T, Yagi Y, Maekita T, Imura M, Nakagawa S, et al. (2004) Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers. Cancer Sci 95:741-744. (Pubitemid 39335094)
19. Stoehr R, Wissmann C, Suzuki H, Knuechel R, Krieg RC, et al. (2004) Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer. Lab Invest 84:465-478. (Pubitemid 41656474)
20. Lee AY, He B, You L, Dadfarmay S, Xu Z, et al. (2004) Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Oncogene 23:6672-6676. (Pubitemid 39265531)
21. Ugolini F, Charafe-Jauffret E, Bardou VJ, Geneix J, Adelaide J, et al. (2001) WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene 20:5810-5817. (Pubitemid 32937950)
22. Klopocki E, Kristiansen G, Wild PJ, Klaman I, Castanos-Velez E, et al. (2004) Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. Int J Oncol 25:641-649.
23. Zou H, Molina JR, Harrington JJ, Osborn NK, Klatt KK, et al. (2005) Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int J Cancer 116: 584-591. (Pubitemid 41099195)
24. Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H (2005) Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 65: 4218-4227. (Pubitemid 40775660)
25. Byun T, Karimi M, Marsh JL, Milovanovic T, Lin F, et al. (2005) Expression of secreted Wnt antagonists in gastrointestinal tissues: potential role in stem cell homeostasis. J Clin Pathol 58: 515-519. (Pubitemid 40646873)
26. Andresen K, Boberg KM, Vedeld HM, Honne H, Hektoen M, et al. (2012) Novel target genes and a valid biomarker panel identified for cholangiocarcinoma. Epigenetics 7: 1249-1257.
27. Yan D, Wallingford JB, Sun TQ, Nelson AM, Sakanaka C, et al. (2001) Cell autonomous regulation of multiple disheveled-dependent pathways by mammalian Nkd. Proc. Natl. Acad. Sci. USA 98: 3802-3807. (Pubitemid 32249852)
28. Fraumeni JF Jr, Devesa SS, McLaughlin JK, Stanford JL (1996) Biliary tract cancer. In: D. Schottenfeld and J.F. Fraumeni, Jr(eds.), Cancer epidemiology and prevention (Ed.2) Oxford University Press, New York 794-805.
29. Hsing AW, Gao YT, Devesa SS, Jin F, Fraumeni JF Jr (1998) Rising incidence of biliary tract cancer in Shanghai, China. Int. J. Cancer 73: 368-370. (Pubitemid 28100037)
30. Feinberg AP, Tycko B (2004) The history of cancer epigenetics. Nat Rev Cancer 4: 143-153. (Pubitemid 38198742)
31. Stoehr R, Wissmann C, Suzuki H, Knuechel R, Krieg RC, et al. (2004) Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer. Lab Invest 84: 465-478. (Pubitemid 41656474)
32. You J, Wen L, Roufas A, Madigan MC, Sutton G (2013) Expression of SFRP Family Proteins in Human Keratoconus Corneas. Plos One 18: 8.
33. Huang J, Zhang YL, Teng XM, Lin Y, Zheng DL, et al. (2007) Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellularcarcinoma. BMC Cancer 7: 126.
34. Finch PW, He X, Kelley MJ, Uren A, Schaudies RP, et al. (1997) Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci USA 94: 6770-6775. (Pubitemid 27281939)
35. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, et al. (2002) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31: 141-149.
36. Caldwell GM, Jones C, Gensberg K, Jan S, Hardy RG, et al. (2004) The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res 64: 883-888. (Pubitemid 38176888)
37. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, et al. (2002) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31:141-149.
38. Marsit CJ, Karagas MR, Andrew A, Liu M, Danaee H, et al. (2005) Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer. Cancer Res 65: 7081-7085. (Pubitemid 41161235)
39. Suzuki M, Shigematsu H, Nakajima T, Kubo R, Motohashi S, et al. (2007) Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non small cell lung cancer. Clin Cancer Res 13: 6087-6092. (Pubitemid 350075066)
40. Goeppert B, Konermann C, Schmidt CR, Bogatyrova O, Geiselhart L, et al. (2013) Global alterations of DNA methylation in cholangiocarcinoma targets the Wnt signaling pathway. Hepatology 59: 544-548.
41. Andresen K, Boberg KM, Vedeld HM, Honne H, Hektoen M, et al. (2012) Novel target genes and a valid biomarker panel identified for cholangiocarcinoma. Epigenetics 7: 1249-1257.
42. Xi S, Yang M, Tao Y, Xu H, Shan J, et al. (2010) Cigarette Smoke Induces C/EBP-β-Mediated Activation of miR-31 in Normal Human Respiratory Epithelia and Lung Cancer Cell. Plos One 29: 5.
43. Sun X, He Y, Huang C, Ma TT, Li J (2013) Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway. Cell Signal 25: 2805-2811.